Compare Elder Pharma with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA ABBOTT INDIA ELDER PHARMA/
ABBOTT INDIA
 
P/E (TTM) x -0.2 51.2 - View Chart
P/BV x 0.1 12.4 0.8% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ELDER PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ABBOTT INDIA
Mar-19
ELDER PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3808,834 4.3%   
Low Rs1885,458 3.4%   
Sales per share (Unadj.) Rs491.21,731.1 28.4%  
Earnings per share (Unadj.) Rs-3.2211.9 -1.5%  
Cash flow per share (Unadj.) Rs14.4219.9 6.6%  
Dividends per share (Unadj.) Rs065.00 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs376.5945.2 39.8%  
Shares outstanding (eoy) m20.5421.25 96.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.64.1 14.0%   
Avg P/E ratio x-89.333.7 -264.7%  
P/CF ratio (eoy) x19.732.5 60.7%  
Price / Book Value ratio x0.87.6 10.0%  
Dividend payout %030.7 0.0%   
Avg Mkt Cap Rs m5,833151,848 3.8%   
No. of employees `000NA3.5 0.0%   
Total wages/salary Rs m2,1794,356 50.0%   
Avg. sales/employee Rs ThNM10,555.5-  
Avg. wages/employee Rs ThNM1,249.9-  
Avg. net profit/employee Rs ThNM1,292.2-  
INCOME DATA
Net Sales Rs m10,08936,786 27.4%  
Other income Rs m2571,133 22.6%   
Total revenues Rs m10,34637,919 27.3%   
Gross profit Rs m-7926,047 -13.1%  
Depreciation Rs m361169 213.5%   
Interest Rs m2,75623 12,250.2%   
Profit before tax Rs m-3,6536,989 -52.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1252,485 5.0%   
Profit after tax Rs m-654,503 -1.5%  
Gross profit margin %-7.816.4 -47.7%  
Effective tax rate %-3.435.6 -9.6%   
Net profit margin %-0.612.2 -5.3%  
BALANCE SHEET DATA
Current assets Rs m9,24027,610 33.5%   
Current liabilities Rs m9,9988,569 116.7%   
Net working cap to sales %-7.551.8 -14.5%  
Current ratio x0.93.2 28.7%  
Inventory Days Days4660 76.9%  
Debtors Days Days6027 218.8%  
Net fixed assets Rs m10,1241,057 957.9%   
Share capital Rs m206213 96.8%   
"Free" reserves Rs m5,58219,873 28.1%   
Net worth Rs m7,73420,086 38.5%   
Long term debt Rs m4,8890-   
Total assets Rs m22,88229,409 77.8%  
Interest coverage x-0.3311.6 -0.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.41.3 35.2%   
Return on assets %11.815.4 76.4%  
Return on equity %-0.822.4 -3.8%  
Return on capital %22.334.9 63.9%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m307369 83.1%   
Fx outflow Rs m1254,918 2.5%   
Net fx Rs m181-4,549 -4.0%   
CASH FLOW
From Operations Rs m11,7544,991 235.5%  
From Investments Rs m-561-2,570 21.8%  
From Financial Activity Rs m-6,762-1,428 473.5%  
Net Cashflow Rs m4,432993 446.2%  

Share Holding

Indian Promoters % 39.6 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 7.5 7.9 94.9%  
FIIs % 16.8 0.1 16,800.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 17.1 211.1%  
Shareholders   16,479 18,270 90.2%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   IPCA LABS  SANOFI INDIA  UNICHEM LAB  DR. DATSONS LABS  AJANTA PHARMA  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS